Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,167
Total Claims
$1.6M
Drug Cost
1,054
Beneficiaries
$1,565
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+11%
Cost per patient vs peers
$1,565 vs $1,411 avg
+70%
Brand preference vs peers
18.1% vs 10.6% avg
Brand vs Generic
Brand: 3,979 claims · $1.1M
Generic: 18,065 claims · $544K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 984 | $285K |
| Paliperidone Palmitate | 14 | $45K |
| Rivaroxaban | 152 | $44K |
| Epoetin Alfa | 66 | $43K |
| Sitagliptin Phosphate | 141 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 98 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 225 | $33K |
| Collagenase Clostridium Hist. | 53 | $33K |
| Rifaximin | 21 | $30K |
| Sacubitril/Valsartan | 62 | $26K |
| Risperidone Microspheres | 19 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 193 | $22K |
| Sevelamer Carbonate | 38 | $21K |
| Divalproex Sodium | 301 | $18K |
| Potassium Chloride | 435 | $17K |
Prescribing Profile
Patient Profile
76
Avg Age
57%
Female
3.34
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data